This is the last of a series of articles on invasive fungal infections prepared by opinion leaders in Turkey. The aim of these articles is to guide clinicians in managing invasive fungal diseases in hematological malignancies and stem cell transplantation based on the available best evidence in this field. The previous articles summarized the diagnosis and treatment of invasive fungal disease and this article aims to explain the risk categorization and guide the antifungal prophylaxis in invasive fungal disease
There is a strong argument for the use of antifungal prophylaxis in high-risk patients given the sig...
In recent years, prospective studies have been conducted to assess the role of prophylaxis and treat...
In recent years, prospective studies have been conducted to assess the role of prophylaxis and treat...
This is the last of a series of articles on invasive fungal infections prepared by opinion leaders i...
This is the last of a series of articles on invasive fungal infections prepared by opinion leaders i...
The introduction of novel antifungal agents for the treatment of invasive fungal disease in hematolo...
The introduction of novel antifungal agents for the treatment of invasive fungal disease in hematolo...
The introduction of novel antifungal agents for the treatment of invasive fungal disease in hematolo...
Invasive fungal infections (IFIs) are an important cause of morbidity and mortality in immunocomprom...
Invasive fungal diseases are associated with significantmorbidity and mortality among neutropenic pa...
. These authors contributed equally to this work. Background: Invasive fungal disease (IFD) causes m...
Invasive fungal infection (IFI) is a persistent problem among critically ill and immunocompromised p...
OBJECTIVE: Patients with hematologic malignancies are at substantial risk of developing invasive fun...
In recent years, prospective studies have been conducted to assess the role of prophylaxis and treat...
There is a strong argument for the use of antifungal prophylaxis in high-risk patients given the sig...
In recent years, prospective studies have been conducted to assess the role of prophylaxis and treat...
In recent years, prospective studies have been conducted to assess the role of prophylaxis and treat...
This is the last of a series of articles on invasive fungal infections prepared by opinion leaders i...
This is the last of a series of articles on invasive fungal infections prepared by opinion leaders i...
The introduction of novel antifungal agents for the treatment of invasive fungal disease in hematolo...
The introduction of novel antifungal agents for the treatment of invasive fungal disease in hematolo...
The introduction of novel antifungal agents for the treatment of invasive fungal disease in hematolo...
Invasive fungal infections (IFIs) are an important cause of morbidity and mortality in immunocomprom...
Invasive fungal diseases are associated with significantmorbidity and mortality among neutropenic pa...
. These authors contributed equally to this work. Background: Invasive fungal disease (IFD) causes m...
Invasive fungal infection (IFI) is a persistent problem among critically ill and immunocompromised p...
OBJECTIVE: Patients with hematologic malignancies are at substantial risk of developing invasive fun...
In recent years, prospective studies have been conducted to assess the role of prophylaxis and treat...
There is a strong argument for the use of antifungal prophylaxis in high-risk patients given the sig...
In recent years, prospective studies have been conducted to assess the role of prophylaxis and treat...
In recent years, prospective studies have been conducted to assess the role of prophylaxis and treat...